Wound healing simplified. Many wound care physicians get frustrated when applying amniotic tissue sheet products to their patients with chronic wounds when the sheet tears or folds over. Our BioHeal Hydrogel allows physicians to easily apply our patented technology to support natural wound healing without wasting money or time. (Not available in US).
BIOHEAL THERAPEUTICS is a global regenerative medicine company focused on amnion derived technologies that could disrupt traditional hard to apply, painful and expensive to transport and store treatment options for healing of chronic wounds and severe burns.
BIOHEAL THERAPEUTICS signed an exclusive worldwide licensing agreement with the Wake Forest Institute for Regenerative Medicine (WFIRM), a research institute affiliated with Wake Forest School of Medicine, for development and commercialization rights for amnion derived technologies shown to support wound closure for the protection, healing and repair of chronic wounds and severe burns.
The company is rapidly building a portfolio of patented regenerative treatment product candidates to improve patients’ outcomes along with reducing pain and lowering costs. Founded by Bruce Anderson and Steve Anderson of Kennesaw, Georgia and Longboat Key, Florida respectively, the company has more than 20 years’ global experience developing, manufacturing, processing and commercializing more than 20 implantable human cardiovascular and orthopedic tissues as well as Class II and III medical devices.
BIOHEAL THERAPEUTICS was formed in Florida and is headquartered in suburban Atlanta, Georgia. We are committed to delivering innovative, proprietary & patented medical devices that are bioengineered to support wound closure and healthy tissue to improve patients' lives.
Meet the Team
Mr. Anderson was Chairman of the Board and co-founder of BIOHEAL THERAPEUTICS, LLC from 2017 until his passing in 2023. Mr. Anderson was co-founder, President/CEO of CryoLife, Inc. (now Artivion) from 1984 - 2015. He took the company public on Nasdaq in 1994 and moved it to the NYSE in 1997. Prior to that he was Executive Vice President of Intermedics, Inc. (now Boston Scientific) from 1976 to 1983. From 1973 to 1976 he was President of US Operations for Biotronik, Inc. He was the top sales representative and region manager for Medtronic from 1968 - 1973. He was an entrepreneur, pioneer and leader in the medical device industry. CryoLife cardiac tissues revolutionized pediatric cardiac reconstructive surgery and helped save the lives of thousands of children. CryoLife vascular tissues helped save the limbs of thousands of adults with peripheral vascular disease. CryoLife products have been used in 80 different countries. He was one of a handful of people in medical devices to start a company, take it public and run day to day operations as President/CEO for over 30 years. He was a graduate of the University of Minnesota at Minneapolis.
President & CEO
Bruce Anderson, President/CEO. Mr. Anderson has more than 20 years global experience developing, manufacturing, processing and commercializing over 20 implantable human cardiovascular and orthopedic tissues as well as Class II and III medical devices. Elected in 2014, Mr. Anderson has served as Vice President of US Sales and Global Marketing for CryoLife (now Artivion). During this time, he led a team of over 120 people, including all worldwide product marketing functions for the company. Prior to that, he was elected and has served as Vice President, US Sales and Marketing in 2008. From 2002 to 2007, he was Director of US Sales, leading the sales team to double digit growth. CryoLife's preserved human tissues and surgical adhesives have been implanted in and improved the lives of about 2 million people. He is a graduate of the University of South Florida at Tampa.